Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
暂无分享,去创建一个
H. Weiner | M. Sayegh | W. Hancock | C. Carpenter | C. Kwok | Howard L. Weiner | Wayne W. Hancock | Cheng A. Kwok